Table 2.
Multivariate logistic analysis with corresponding predictive accuracy for each variable
| Variables | Biopsy outcome of prostate cancer | Biopsy outcome of HGPCa | ||||
|---|---|---|---|---|---|---|
| OR (95%CI) | P Value | AUC | OR (95%CI) | P Value | AUC | |
| Age (Continuous) | 1.04 (0.95‐1.14) | .39 | 0.52 | 0.97 (0.85‐1.10) | .63 | 0.55 |
| f/t PSA ratio (Continuous) | 0.88 (0.79‐0.99) | .031 | 0.65 | 0.85 (0.73‐0.99) | .039 | 0.66 |
| Serum PSA (Continuous) | 1.11 (0.98‐1.26) | .098 | 0.58 | 1.19 (1.01‐1.40) | .043 | 0.62 |
| DRE, n, (Abnormal) | 3.11 (0.35‐27.85) | .31 | 0.51 | 1.31 (0.071‐24.45) | .86 | 0.51 |
| ASAP history (Present) | 7.10 (1.31‐38.57) | .023 | 0.60 | 2.31 (0.14‐37.84) | .56 | 0.53 |
| HGPIN history (Present) | 2.62 (0.37‐18.53) | .34 | 0.52 | 5.14 (0.28‐96.13) | .27 | 0.52 |
| Biomarker index | 1.06 (1.03‐1.09) | <.001 | 0.72 | 1.08 (1.03‐1.13) | .002 | 0.73 |
Abbreviations: AUC: Area under curve;CI: Confidence interval; HGPCa: High grade prostate cancer; OR: odd ratio.